The board of state gas utility GAIL India Ltd will on March 31 consider the buyback of shares - the second buyback in as many years
Also proposes shortening the share tendering process by five days in the case of both buybacks and open offers
Over 301 million shares tendered in buyback-8.5 times the company intended to repurchase. Attractive buyback price lured investors into tendering their shares, say experts
Acceptance ratio is lower than previous buybacks done by the firm
According to an analysis done by Edelweiss Alternative Research, the acceptance ratio of TCS share buyback for retail investors could be 14.3 per cent
The mega Rs 18,000-crore buyback by IT giant Tata Consultancy Services (TCS) opens today and will run till March 23
Tata Consultancy Services (TCS) on Monday said its Rs 18,000 crore share buyback offer will open on March 9 and close on March 23.
The buyback of shares will be at a price not exceeding Rs 875 per equity share through the open market route
In the past one week, the stock of UPL has corrected 13 per cent as compared to 6 per cent decline in the S&P BSE Sensex
TCS on January 12, 2022 had approved to buyback up to 40 million equity shares of face value of Rs 1 each at Rs 4,500 per equity share for an aggregate amount of upto Rs 18,000 crore.
The company fixed February 23, 2022, as the record date for the Rs 18,000 crore share buyback plan.
The company's board will meet on February 9, 2022 to consider the proposal for buyback of equity shares of the company through tender offer route.
The company had already pledged to give back to investors $5.5 billion of the cash proceeds from the sale of its Permian-basin oil assets.
At Rs 4,500 apiece, the two entities stand to rake in about Rs 12,993.2 cr
The stock was up 3% at Rs 3,979.90, trading close to its record high level of Rs 3,990 touched on October 8, 2021.
The average buyback amounts have fallen for listed firms, shows Prime data analysis
Drug firm Ajanta Pharma said its board has approved a share buyback plan of up to Rs 286-crore, wherein the drug maker will buy back shares at a maximum price of Rs 2,550 apiece.
The board of directors of the company is scheduled to consider a proposal for buy-back of equity shares on Tuesday, December 28.
The board of directors are scheduled to meet on Monday December 27, 2021 to consider and approve a proposal for buy-back of equity shares of the company.
It has also commenced an initial share repurchase programme of its ordinary shares up to £20 million as a prelude to the anticipated larger buyback programme